"Pyridostigmine Bromide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.
| Descriptor ID |
D011729
|
| MeSH Number(s) |
D03.383.725.762.740
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pyridostigmine Bromide".
Below are MeSH descriptors whose meaning is more specific than "Pyridostigmine Bromide".
This graph shows the total number of publications written about "Pyridostigmine Bromide" by people in this website by year, and whether "Pyridostigmine Bromide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pyridostigmine Bromide" by people in Profiles.
-
Boerner RM, Young DL, Gnagi SH, White DR, Halstead LA. Pyridostigmine for the Reversal of Severe Adverse Reactions to Botulinum Toxin in Children. J Pediatr. 2018 03; 194:241-243.
-
Young DL, Halstead LA. Pyridostigmine for reversal of severe sequelae from botulinum toxin injection. J Voice. 2014 Nov; 28(6):830-4.
-
Pineles SL, Avery RA, Moss HE, Finkel R, Blinman T, Kaiser L, Liu GT. Visual and systemic outcomes in pediatric ocular myasthenia gravis. Am J Ophthalmol. 2010 Oct; 150(4):453-459.e3.
-
Blonski W, Vela MF, Freeman J, Sharma N, Castell DO. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. J Clin Gastroenterol. 2009 Mar; 43(3):253-60.
-
Hudspeth MP, Holden KR, Crawford TO. The "slurp" test: bedside evaluation of bulbar muscle fatigue. Pediatrics. 2006 Aug; 118(2):e530-3.
-
Wang JQ, Miller MA, Fei X, Stone KL, Lopshire JC, Groh WJ, Zipes DP, Hutchins GD, Zheng QH. Facile synthesis and initial PET imaging of novel potential heart acetylcholinesterase imaging agents [11C]pyridostigmine and its analogs. Nucl Med Biol. 2004 Oct; 31(7):957-64.
-
Peden-Adams MM, Dudley AC, EuDaly JG, Allen CT, Gilkeson GS, Keil DE. Pyridostigmine bromide (PYR) alters immune function in B6C3F1 mice. Immunopharmacol Immunotoxicol. 2004 Feb; 26(1):1-15.
-
Peden-Adam MM, Eudaly J, Eudaly E, Dudley A, Zeigler J, Lee A, Robbs J, Gilkeson G, Keil DE. Evaluation of immunotoxicity induced by single or concurrent exposure to N,N-diethyl-m-toluamide (DEET), pyridostigmine bromide (PYR), and JP-8 jet fuel. Toxicol Ind Health. 2001 Jun; 17(5-10):192-209.